Key Market Indicators
Serbian insulin imports are set to fall by 5.8% year on year, from $13 million in 2021 to $9 million by 2026. This follows an average 7.6% growth in the country's demand for insulin since 2010. In 2018, Serbia ranked 59th in the world for insulin imports, though this was down from the previous year when El Salvador overtook with $2 million in imports. France, Italy, and China came second, third, and fourth, respectively.
